{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:54:02Z","timestamp":1773712442878,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2856,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.fertnstert.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T13:22:40Z","timestamp":1402924960000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells"],"prefix":"10.1016","volume":"102","author":[{"given":"Md Soriful","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Protic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ciavattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano Raffaele","family":"Giannubilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Luigi","family":"Tranquilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-3786","authenticated-orcid":false,"given":"Pasquapina","family":"Ciarmela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.05.013_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Day Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.2870110102","article-title":"Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata","volume":"11","author":"Mashal","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1098-2264(200007)28:3<235::AID-GCC1>3.0.CO;2-7","article-title":"Genetics of uterine leiomyomata","volume":"28","author":"Ligon","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","article-title":"Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder","volume":"28","author":"Chegini","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","article-title":"Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids","volume":"40","author":"Catherino","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2014.05.013_bib11","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.fertnstert.2004.04.030","article-title":"Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium","volume":"82","author":"Leppert","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib14","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib16","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.fertnstert.2010.12.028","article-title":"Increased type I and V collagen expression in uterine leiomyomas during the menstrual cycle","volume":"95","author":"Iwahashi","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2012.02.037","article-title":"Development and validation of a three-dimensional in\u00a0vitro model for uterine leiomyoma and patient-matched myometrium","volume":"97","author":"Malik","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.07.1123","article-title":"Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production","volume":"98","author":"Britten","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib19","first-page":"602","article-title":"Histological and biochemical studies of collagen in human uterine leiomyomas","volume":"60","author":"Fujita","year":"1985","journal-title":"Hokkaido Igaku Zasshi"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib20","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","article-title":"Mechanical homeostasis is altered in uterine leiomyoma","volume":"198","author":"Rogers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.matbio.2011.09.001","article-title":"Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma","volume":"31","author":"Norian","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2012.09.005","article-title":"Integrin \u03b21 regulates leiomyoma cytoskeletal integrity and growth","volume":"31","author":"Malik","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1476-5381.1976.tb08614.x","article-title":"Pharmachological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent","volume":"58","author":"Azuma","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib24","first-page":"169","article-title":"Suppressive effects of tranilast (TN) on human mononuclear cells","volume":"7","author":"Yanagi","year":"1987","journal-title":"Jpn J Inflamm"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0021-5198(19)43349-0","article-title":"Study of the mechanism of inhibitory action of tranilast on chemical mediator release","volume":"46","author":"Komatsu","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(01)01215-8","article-title":"Tranilast inhibits interleukin-1\u03b2-induced monocyte chemoattractant protein-1 expression in rat mesangial cells","volume":"427","author":"Chikaraishi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BJ20111996","article-title":"Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition","volume":"443","author":"Carrino","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","article-title":"Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts","volume":"116","author":"Yamada","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib30","doi-asserted-by":"crossref","first-page":"PL287","DOI":"10.1016\/0024-3205(94)00668-7","article-title":"Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in\u00a0vivo and of morphological changes and functions of fibroblasts in\u00a0vitro","volume":"55","author":"Isaji","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0701493","article-title":"Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in\u00a0vitro and angiogenesis in\u00a0vivo","volume":"122","author":"Isaji","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-5198(19)32429-1","article-title":"The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0022-3565(24)39006-8","article-title":"Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis","volume":"295","author":"Capper","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0021-9150(95)05709-9","article-title":"Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells","volume":"121","author":"Miyazawa","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0922-4106(95)90087-X","article-title":"Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide","volume":"291","author":"Hishikawa","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0026-895X(25)09376-9","article-title":"Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells","volume":"50","author":"Nie","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib37","first-page":"2471","article-title":"Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders","volume":"32","author":"Rogosnitzky","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib38","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1210\/jc.2002-020444","article-title":"Tranilast inhibits the proliferation of uterine leiomyoma cells in\u00a0vitro through G1 arrest associated with the induction of p21waf1 and p53","volume":"87","author":"Shime","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib39","first-page":"321","article-title":"Antiproliferative effect of tranilast on human myometrial and leiomyoma cells","volume":"2","author":"Islam","year":"2012","journal-title":"Biol Biomed Rep"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib40","first-page":"69","article-title":"Generation of immortal human prostate cell lines for the study of prostate cancer","volume":"81","author":"Rhim","year":"2003","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jcp.22907","article-title":"Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in\u00a0vitro studies","volume":"227","author":"Ciarmela","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib43","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.fertnstert.2012.07.1132","article-title":"Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent","volume":"98","author":"Gilden","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib44","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1210\/jc.2013-2623","article-title":"Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function","volume":"99","author":"Islam","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/y95-230","article-title":"Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells","volume":"74","author":"Fukuyama","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0021-9150(94)90019-1","article-title":"Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells","volume":"107","author":"Tanaka","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ki.5000189","article-title":"Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells","volume":"69","author":"Qi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib48","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1242\/jcs.113.13.2455","article-title":"Impaired wound healing in embryonic and adult mice lacking vimentin","volume":"113","author":"Eckes","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1146\/annurev.bi.52.070183.003553","article-title":"Cell surface interactions with extracellular materials","volume":"52","author":"Yamada","year":"1983","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib51","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.01.081","article-title":"Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3","volume":"93","author":"Joseph","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib52","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2008.03.045","article-title":"Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression","volume":"91","author":"Malik","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2010-0501","article-title":"Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid","volume":"96","author":"Ciarmela","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib55","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1074\/jbc.M610764200","article-title":"Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12","volume":"282","author":"Kang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib56","first-page":"G1059","article-title":"TGF-\u03b21 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis","volume":"276","author":"Kanzler","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib57","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ki.1997.190","article-title":"TGF-beta in kidney fibrosis: a target for gene therapy","volume":"51","author":"Border","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib58","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/labinvest.3700191","article-title":"Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice","volume":"84","author":"Nagashio","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/mgme.2000.3032","article-title":"Induction of cardiac fibrosis by transforming growth factor-beta1","volume":"71","author":"Lijnen","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/bbrc.1996.1508","article-title":"Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells","volume":"227","author":"Ikeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.1289","article-title":"N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells","volume":"93","author":"Platten","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(95)05607-6","article-title":"Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"118","author":"Miyazawa","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib63","doi-asserted-by":"crossref","first-page":"p83","DOI":"10.1159\/000074845","article-title":"Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy","volume":"95","author":"Mifsud","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib64","doi-asserted-by":"crossref","first-page":"C1331","DOI":"10.1152\/ajpcell.00373.2006","article-title":"The role of the activin system in keloid pathogenesis","volume":"292","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0016-5085(98)70539-6","article-title":"Expression of activin A is increased in cirrhotic and fibrotic rat livers","volume":"114","author":"Sugiyama","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib66","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/gut.52.10.1487","article-title":"Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis","volume":"52","author":"Ohnishi","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.ASN.0000103225.68136.E6","article-title":"Activin A is a potent activator of renal interstitial fibroblasts","volume":"15","author":"Yamashita","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib68","first-page":"707","article-title":"Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis","volume":"148","author":"Matsuse","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.bjp.0706460","article-title":"Transcriptional activation of p21 by Tranilast is mediated via transforming growth factor beta signal pathway","volume":"147","author":"Charng","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib70","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CAD.0b013e328327994e","article-title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","volume":"20","author":"Chakrabarti","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/02844319709085482","article-title":"Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast","volume":"31","author":"Shigeki","year":"1997","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib72","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib73","first-page":"141","article-title":"Tranilast Kissei Pharmaceutical","volume":"1","author":"Konneh","year":"1998","journal-title":"IDrugs"},{"key":"10.1016\/j.fertnstert.2014.05.013_bib74","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00004872-200405000-00006","article-title":"Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug","volume":"22","author":"Pfab","year":"2004","journal-title":"J Hypertens"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214004610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214004610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:14:12Z","timestamp":1758010452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214004610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0015028214004610"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.05.013","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}